written by reader EARS

By Anonymous Questions, January 12, 2016

All of the major financial advisors were hyping some big announcement to occur right after the first of the year that was going to cause EARS stock price to rocket higher.

Given what’s actually happened, would you classify that as a classical ’pump and dump’ scheme on a very broad basis?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

12 Comments
Inline Feedbacks
View all comments
Travis Johnson, Stock Gumshoe
January 12, 2016 9:26 pm

Did they say what the event would be? I don’t remember anything other than finding enough clues to ID the stock, but newsletters often exaggerate the potential catalysts in their ads — they generally don’t care if you buy the stock, they don’t profit from that, they profit from subscriptions… And people won’t buy subscriptions as merrily unless they can create an urgent reason for you to subscribe RIGHT NOW.

Add a Topic
5971
Add a Topic
5971
๐Ÿ‘ 17846
SoGiAm
Irregular
January 12, 2016 9:32 pm

Major financial experts record of success may be checked for free or for relatively small cost here: https://www.tipranks.com/stocks/ears Best2All-Ben

๐Ÿ‘ 11521
Wayne's Word
January 14, 2016 4:10 pm

Travis: “And people wonโ€™t buy subscriptions as merrily unless they can create an urgent reason for you to subscribe RIGHT NOW.”….exactly, which is why (days ago) I questioned whether anyone heard of disappointing news or a lack of “touted” anticipated news.

@ Anonymous Questions, how do you define ” major financial advisors”? The only teaser article I was aware of, came from Money Map Press. They did not suggest a time frame. Were there others? What had you heard?

Add a Topic
605
David Nemes
Guest
David Nemes
January 21, 2016 3:42 am

From the 3rd quarter report:
“The Company expects to have first top-line Phase 3 clinical data for AM-101 in the second quarter of 2016”. The drug is meant to reduce the symptoms of tinnitus.

Add a Topic
5344
guatdodger
Member
July 23, 2016 11:23 am
Reply to  David Nemes

Ears now has 2 top-line Phase 3 tests coming. First is due on 8/31 and the second in the 4th quarter. This is for their drug AM-101. The Phase 3 testing results for their other drug AM-111 is due 4th quarter 17. There is no competition for treatment of inner ear tinnitus.

Add a Topic
5344
๐Ÿ‘ 82
mcp_independent311
January 13, 2016 8:24 pm